Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2RL3 | Q96RI0 | 6/20 | 0.38 |
| ▸ | PDE2A | O00408 | 3/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | SCP2 | P22307 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.35 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.35 |
| ▸ | ACSL6 | Q9UKU0 | 1/20 | 0.35 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.34 |
| ▸ | ALB | P02768 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16815261 | 0.94 | F2RL3 (0.37) | F2RL3PDE2APDE3BPDE3AP2RY12 | |
| SCHEMBL16848747 | 0.88 | TLR9 (0.44) | PDE2APDE3BPDE3AP2RY12MAPT | |
| Glycinebetaine SCHEMBL16817805 | 0.87 | F2RL3 (0.34) | F2RL3PDE2APDE3BPDE3AP2RY12 | |
| SCHEMBL16848786 | 0.86 | F2RL3 (0.35) | F2RL3PDE3BPDE3AP2RY12TP53 | |
| SCHEMBL16848750 | 0.86 | FABP3 (0.33) | TP53MAPT | |
| SCHEMBL16815343 | 0.85 | FABP3 (0.32) | — | |
| SCHEMBL16815200 | 0.83 | ESR1 (0.44) | PDE3AMAOAALB | |
| SCHEMBL16848749 | 0.83 | LTB4R (0.33) | — | |
| Bromide SCHEMBL16817795 | 0.82 | ESR1 (0.43) | PDE3AMAOAALB | |
| SCHEMBL16848758 | 0.82 | ACSL1 (0.41) | F2RL3PDE2APDE3BPDE3AP2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9453010-B2 | Marker dyes for UV and short wave excitation with high stokes shift based on benzoxazoles | DYOMICS GMBH (DE) | 2016-09-27 | — | — | US | disclosed |
| US-20150175591-A1 | MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES | DYOMICS GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175591-A1 | MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES | NR2E3, H1-10, NR0B1 | F2RL3 3165/4885PDE2A 4848/4885PDE3B 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.